Alexey StryginDo GLP-1s delay aging?I’ve been in the GLP-1 drug space for almost 4 years, well before the current hype. Here’s my take on @BBCNews’ ‘delay aging’ claim based…Sep 2Sep 2
Alexey StryginRevealed preference for an extremely long (infinite?) life.Unless you are not in the longevity industry, you would be surprised to learn that when you poll people asking them the question, “Given…Feb 12Feb 12
Alexey StryginHealthy Ageing MythsWhat Aging Myths do you know? This summer, I was asked to contribute to Huel review on Healthy Aging, which I gladly did and totally forgot…Feb 19, 2023Feb 19, 2023
Alexey StryginTry and fail. Don’t fail to try. A review of the book “Power Law” by Sebastian MallabyThis is the dive into the history and philosophy of venture capital. Kleiner Perkins finally is not just several random names for me but…Feb 12, 2023Feb 12, 2023
Alexey StryginToday is my birthday. I want 3 minutes of your attention and a coffee as a giftI ask for a tiny Birthday gift — 3 minutes of your attention and a coffee.Feb 5, 2023Feb 5, 2023
Alexey Stryginintldr-bioInovio. +600% за год не предел роста? (Часть 1)Оцениваем компанию-разработчика вакцины от COVID-19Jul 30, 2020Jul 30, 2020
Alexey Stryginintldr-bioМодерна показала неплохие результаты фазы I, но безопасность под вопросом14 июля Moderna (NASDAQ:MRNA) опубликовала более подробную информацию о промежуточных данных первой фазы по вакцине КОВИД-19 [1], что…Jul 16, 2020Jul 16, 2020
Alexey Stryginintldr-bioModerna. Скачки на миллиарды.Инвестировать в лидера в разработке вакцины? Инсайдеры продают доли — бегство с тонущего корабля?May 31, 2020May 31, 2020